Tag Archive: FDA

by Chilmark Team | December 18, 2020

Looking to the Future – 2021 Predictions

Unlike past years when we have written a post evaluating how well our predictions for that year held up, let’s […]

by Jody Ranck | October 15, 2020

AI and Recent Regulatory, Policy and Funding Updates

While COVID-19 has been dominating the healthcare headlines so far in 2020 there have been a number of recent policy and regulatory decisions bearing on the AI/ML market in healthcare.

by Alex Lennox-Miller | January 30, 2020

Guidance on Clinical Decision Support: Definitions and Transparency

Roughly two years after we reviewed the first FDA guidance on Clinical Decision Support (CDS), FDA issued new draft guidance. […]

by Chilmark Team | December 10, 2018

2019 Predictions: M&A, Big Tech, and the Fate of ACOs

The Meaningful Use gravy train finally came to an end in 2018. As the strongest EHR vendors struggle to define […]

by Chilmark Team | November 29, 2018

Revisiting Our 2018 Predictions

As is our custom here, we like to look back on our predictions for the closing year and see just […]

by Brian Edwards | December 19, 2017

FDA Guidance on Clinical Decision Support: Peering Inside the Black Box of Algorithmic Intelligence

Key Takeaways: The FDA has released long-anticipated draft guidance on how they intend to regulate clinical decision support products. For […]

by Naveen Rao | July 27, 2015

Connected Care: Are We There Yet?

Progress? Healthcare organizations (HCOs) are acknowledging the need for next generation tools to realize the promise of newer models of […]

by Naveen Rao | March 28, 2015

The Patient Will See You Now

A Worthy Read This month’s Domain Monitor is a little bit different. We recently read through Dr. Eric Topol’s latest […]

Stay up to the minute.

[bestwebsoft_contact_form]